Washington, D.C. (ABC) - A U.S. drug firm has forged ahead in the fight against the Coronavirus.
The biotech company Moderna announced preliminary trials showed a COVID-19 vaccine to be safe and effective.
Early results showed all 45 patients developed the same level of antibodies as someone who has recovered from COVID-19.
The company now heads into phase two of testing. They plan to test 600 patients.
The third phase is expected to begin in July. It will include testing of as many as 10,000 people.